Nurix Therapeutics Inc [NRIX]
Pivot duomenys
Pivot statistika
| Rodiklis | Vidurkis | Mediana | Stand. nuokr. |
|---|---|---|---|
| Prieaugis % | 26.45% | 18.94% | 23.53% |
| Nuostolis % | -13.21% | -12.96% | 4.79% |
| Trukmė | 16.5d | 16d | 8.5d |
| Rasta pivot taškų | 16 |
| Prieaugio/nuostolio atkarpos | 15 (8 Prieaugis / 7 Nuostolis) |
| Paskutinis pivot | Top @ $17.76 data 2026-05-29 |
| Pokytis nuo paskutinio pivot | $-0.81 (-4.56%) |
Kito pivot prognozė Paskutinė: $16.95
| Prognozuojamas kitas tipas | Bottom |
| Prognozuojama kaina (vid.) | $15.41 |
| Prognozuojama kaina (mediana) | $15.46 |
| Prognozuojamas kainos intervalas (~68%) | $14.56 - $16.26 |
| Pokytis iki vidutinio tikslo | $-1.54 (-9.06%) |
| Prognozuojama data (vid.) | 2026-06-14 |
| Prognozuojamas datos intervalas (~68%) | 2026-06-06 - 2026-06-23 |
| Pagrindas | Based on 7 historical losses (Avg: -13.21%, Median: -12.96%, StdDev of Abs: 4.79%) and duration (Avg: 16.5 days, StdDev: 8.5 days) |
| Pastaba | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Slight loss for Nurix Therapeutics Inc.
Nurix Therapeutics Inc (NRIX) stock price edged down slightly on Friday after the stock fell $-0.0300 (-0.18%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.31% rise. With 2.56M shares traded, volume yesterday reached $43.44M. This was 1.47M shares less than the prior day. Compared to the 10-day average of 4.19M shares, volume was less than the average.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is approaching the closest resistance level at $17.00. approximately $0.0500 (0.29%) away. Consolidating near resistance. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -
Nurix Therapeutics Inc Evaluation
- Trumpas balas: 0.82
- Vidutinis balas: 2.50
- Ilgas balas: 2.08